Galmed Pharmaceuticals Ltd. Statistics
Share Statistics
Galmed Pharmaceuticals Ltd. has 1.66M shares outstanding. The number of shares has increased by -56.48% in one year.
| Shares Outstanding | 1.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 9.95% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.64M |
| Failed to Deliver (FTD) Shares | 83 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 45.88K, so 2.77% of the outstanding shares have been sold short.
| Short Interest | 45.88K |
| Short % of Shares Out | 2.77% |
| Short % of Float | 2.8% |
| Short Ratio (days to cover) | 0.27 |
Valuation Ratios
The PE ratio is -0.18 and the forward PE ratio is -2.93.
| PE Ratio | -0.18 |
| Forward PE | -2.93 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.09 |
| P/FCF Ratio | -0.2 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Galmed Pharmaceuticals Ltd..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.81, with a Debt / Equity ratio of 0.
| Current Ratio | 4.81 |
| Quick Ratio | 4.81 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 681.09 |
Financial Efficiency
Return on equity (ROE) is -0.5% and return on capital (ROIC) is 53.82%.
| Return on Equity (ROE) | -0.5% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | 53.82% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.30M |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -35.77% in the last 52 weeks. The beta is 0.8, so Galmed Pharmaceuticals Ltd.'s price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | -35.77% |
| 50-Day Moving Average | 3.12 |
| 200-Day Moving Average | 4.03 |
| Relative Strength Index (RSI) | 61.23 |
| Average Volume (20 Days) | 86.99K |
Income Statement
| Revenue | n/a |
| Gross Profit | -31.00K |
| Operating Income | 7.49M |
| Net Income | -6.91M |
| EBITDA | -6.87M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -30.05 |
Balance Sheet
The company has 2.86M in cash and 41.00K in debt, giving a net cash position of 2.82M.
| Cash & Cash Equivalents | 2.86M |
| Total Debt | 41.00K |
| Net Cash | 2.82M |
| Retained Earnings | -192.95M |
| Total Assets | 20.95M |
| Working Capital | 15.17M |
Cash Flow
In the last 12 months, operating cash flow was -6.14M and capital expenditures 0, giving a free cash flow of -6.14M.
| Operating Cash Flow | -6.14M |
| Capital Expenditures | 0 |
| Free Cash Flow | -6.14M |
| FCF Per Share | -26.68 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -876.09% |
| FCF Yield | -107.98% |
Analyst Forecast
Currently there are no analyst rating for GLMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 30, 2024. It was a backward split with a ratio of 1:12.
| Last Split Date | Aug 30, 2024 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -12.18 |
| Piotroski F-Score | 3 |